- $8.58bn
- $9.35bn
- $4.55bn
- 94
- 42
- 63
- 73
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,138 | 3,379 | 3,960 | 4,515 | 4,553 |
Cost of Revenue | |||||
Gross Profit | 1,048 | 1,190 | 1,338 | 1,505 | 1,578 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,815 | 2,952 | 3,441 | 3,939 | 4,123 |
Operating Profit | 323 | 426 | 518 | 576 | 431 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 322 | 407 | 500 | 553 | 401 |
Provision for Income Taxes | |||||
Net Income After Taxes | 273 | 330 | 410 | 443 | 330 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 274 | 330 | 410 | 443 | 330 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 274 | 330 | 410 | 443 | 330 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.05 | 3.08 | 3.69 | 4.23 | 5.03 |
Dividends per Share |